Bristol-Myers Squibb Co (BMY)
49.14
+0.21
(+0.43%)
USD |
NYSE |
Apr 22, 16:00
49.19
+0.05
(+0.10%)
Pre-Market: 08:19
Bristol-Myers Squibb Price: 49.14 for April 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 22, 2024 | 49.00 | 49.56 | 48.87 | 49.14 | 7.910M |
| Apr 19, 2024 | 48.21 | 49.05 | 48.12 | 48.93 | 10.30M |
| Apr 18, 2024 | 47.93 | 48.40 | 47.62 | 48.30 | 10.92M |
| Apr 17, 2024 | 48.44 | 48.55 | 47.70 | 47.84 | 11.76M |
| Apr 16, 2024 | 48.45 | 48.60 | 48.24 | 48.26 | 11.93M |
| Apr 15, 2024 | 48.36 | 49.10 | 48.12 | 48.51 | 11.94M |
| Apr 12, 2024 | 49.04 | 49.09 | 48.26 | 48.28 | 12.46M |
| Apr 11, 2024 | 50.46 | 50.58 | 49.11 | 49.12 | 11.78M |
| Apr 10, 2024 | 51.04 | 51.28 | 50.28 | 50.29 | 11.49M |
| Apr 09, 2024 | 51.13 | 51.68 | 51.07 | 51.60 | 9.488M |
| Apr 08, 2024 | 51.28 | 51.30 | 50.86 | 51.10 | 12.26M |
| Apr 05, 2024 | 51.19 | 51.45 | 50.77 | 51.32 | 9.096M |
| Apr 04, 2024 | 51.94 | 52.08 | 51.20 | 51.40 | 10.99M |
| Apr 03, 2024 | 52.75 | 52.87 | 52.10 | 52.18 | 10.43M |
| Apr 02, 2024 | 53.10 | 53.35 | 52.53 | 52.74 | 10.23M |
| Apr 01, 2024 | 54.17 | 54.23 | 52.96 | 52.99 | 9.520M |
| Mar 28, 2024 | 53.39 | 54.48 | 53.39 | 54.23 | 14.35M |
| Mar 27, 2024 | 53.00 | 53.69 | 52.85 | 53.25 | 13.08M |
| Mar 26, 2024 | 52.39 | 52.65 | 52.04 | 52.55 | 9.952M |
| Mar 25, 2024 | 52.08 | 52.74 | 51.91 | 52.25 | 12.35M |
| Mar 22, 2024 | 51.65 | 52.45 | 51.52 | 51.93 | 11.73M |
| Mar 21, 2024 | 51.91 | 52.65 | 51.56 | 51.59 | 12.63M |
| Mar 20, 2024 | 51.63 | 52.16 | 51.27 | 51.88 | 10.44M |
| Mar 19, 2024 | 51.76 | 51.93 | 51.39 | 51.80 | 14.59M |
| Mar 18, 2024 | 52.58 | 52.70 | 51.53 | 51.59 | 19.74M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
42.77
Minimum
Jul 22 2019
81.13
Maximum
Dec 02 2022
61.97
Average
62.14
Median
Feb 25 2020
Price Benchmarks
| Amgen Inc | 271.91 |
| Gilead Sciences Inc | 66.96 |
| Johnson & Johnson | 149.12 |
| Karuna Therapeutics Inc (DELISTED) | 329.83 |
| 2seventy bio Inc | 4.65 |
Price Related Metrics
| PE Ratio | 12.73 |
| PS Ratio | 2.269 |
| PEG Ratio | 0.4127 |
| Price to Book Value | 3.376 |
| Price to Free Cash Flow | 8.072 |
| Earnings Yield | 7.86% |
| Market Cap | 99.37B |
| PEGY Ratio | 0.3575 |
| Operating PE Ratio | 12.46 |
| Normalized PE Ratio | 12.97 |